These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 32320737)
1. In silico analysis of long non-coding RNAs in medulloblastoma and its subgroups. Joshi P; Jallo G; Perera RJ Neurobiol Dis; 2020 Jul; 141():104873. PubMed ID: 32320737 [TBL] [Abstract][Full Text] [Related]
2. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes. Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA profiling of pediatric Medulloblastoma. Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022 [TBL] [Abstract][Full Text] [Related]
4. Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis. Joshi K; Yuan M; Katsushima K; Saulnier O; Ray A; Amankwah E; Stapleton S; Jallo G; Taylor MD; Eberhart CG; Perera RJ Acta Neuropathol Commun; 2024 Aug; 12(1):138. PubMed ID: 39198884 [TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis. Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Perek-Polnik M; Krętowski A; Cukrowska B; Grajkowska W; Dembowska-Bagińska B; Matyja E J Neurooncol; 2018 Jun; 138(2):231-240. PubMed ID: 29427151 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs as a predictive markers of group 3 medulloblastomas. Mutlu M; Tekin C; Ak Aksoy S; Taskapilioglu MO; Kaya S; Balcin RN; Ocak PE; Kocaeli H; Bekar A; Tolunay S; Tunca B Neurol Res; 2022 Mar; 44(3):232-241. PubMed ID: 34533098 [TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs in Brain Tumors, the Contribution of lncRNAs, circRNAs, and snoRNAs to Cancer Development-Their Diagnostic and Therapeutic Potential. Latowska J; Grabowska A; Zarębska Ż; Kuczyński K; Kuczyńska B; Rolle K Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977537 [TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup. Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068 [TBL] [Abstract][Full Text] [Related]
9. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813 [TBL] [Abstract][Full Text] [Related]
10. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476 [TBL] [Abstract][Full Text] [Related]
11. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma. Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis. Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples. D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195 [TBL] [Abstract][Full Text] [Related]
14. MRI surrogates for molecular subgroups of medulloblastoma. Perreault S; Ramaswamy V; Achrol AS; Chao K; Liu TT; Shih D; Remke M; Schubert S; Bouffet E; Fisher PG; Partap S; Vogel H; Taylor MD; Cho YJ; Yeom KW AJNR Am J Neuroradiol; 2014 Jul; 35(7):1263-9. PubMed ID: 24831600 [TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells. Varon M; Levy T; Mazor G; Ben David H; Marciano R; Krelin Y; Prasad M; Elkabets M; Pauck D; Ahmadov U; Picard D; Qin N; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B Int J Cancer; 2019 Dec; 145(12):3402-3413. PubMed ID: 31081944 [TBL] [Abstract][Full Text] [Related]
18. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645 [TBL] [Abstract][Full Text] [Related]
19. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma. Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541 [TBL] [Abstract][Full Text] [Related]
20. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma. Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917 [No Abstract] [Full Text] [Related] [Next] [New Search]